Transmedics Group (TMDX) EBITDA (2018 - 2026)
Transmedics Group (TMDX) EBITDA from Mar 31, 2018 to Mar 31, 2026. The TTM Transmedics Group (TMDX) EBITDA is $127M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Transmedics Group (TMDX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +71.84% |
| All Time TTM | +47.83% |
Annual EBITDA change of Transmedics Group (TMDX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $25M | -81.47% |
| 2025 | $136M | +137.15% |
| 2024 | $57M | -378.59% |
| 2023 | -$21M | -26.50% |
| 2022 | -$28M | -25.66% |
| 2021 | -$38M | +51.59% |
| 2020 | -$25M | -12.58% |
| 2019 | -$28M | +45.76% |
| 2018 | -$19M | N/A |